The Workup They Do Not Order

When a lean person loses weight without explanation, medicine asks what is happening. When an obese person gains weight without explanation, medicine asks what she is eating. Two questions for the same clinical event.

Two consultations

Consider two patients seen the same week in the same clinic.

The first is a lean woman of fifty-five. She reports having lost five kilos over three months without any change to her diet. Her doctor does not tell her to eat more. She leaves with a lab slip for TSH, fasting glucose, HbA1c, a CBC, and a CRP. Depending on local practice, chest imaging or an abdominal ultrasound may follow. The workup is on. The weight loss is treated as a signal from a body that has something to report.

The second is an obese woman of fifty-five. She reports having gained five kilos over three months without any change to her diet. She leaves with a nutrition brochure, a reminder to move, and a follow-up in six months. No lab slip. No TSH. No fasting insulin. No ferritin. No sleep study. The weight gain is treated as a failure of conduct.

The clinical event is the same, in opposite directions. The workups are not. The only variable that decided which protocol was applied was the body that presented itself.

The formula

When a lean person loses weight, medicine asks what is happening. When an obese person gains weight, medicine asks what are you eating.

Two questions for the same event. The first is diagnostic. The second is disciplinary.

The contradiction inside

Medicine already knows that body weight can move without any change in what the person eats. It knows because it treats the loss half of that observation as a symptom every single day. The unexplained loss triggers a workup, and the workup often finds a thyroid, a diabetes, a malabsorption, a cancer, a depression. The workup exists because the profession understands, without saying so, that weight is a regulated quantity and that the regulator can fail. When it fails toward loss, the profession looks for the fault. When it fails toward gain, the profession looks at the patient.

The theory that eating and moving are the two variables that decide weight is not a theory the profession takes seriously in its own practice. It is a story the profession tells to a subset of its patients. To another subset, the same profession applies a different framework, in which weight is a signal from a machinery worth investigating. The framework is applied selectively. The selection is not made on physiological grounds. It is made on the visual and moral valence of the body in front of the clinician.

When counter-examples arise in the population medicine wants to investigate, tests are ordered. When counter-examples arise in the population medicine wants to admonish, ad hoc rescues are invented: the patient underestimates, the patient cheats, the metabolism has adapted, the effort was insufficient. A theory that cannot fail because the patient is always at fault has left the domain of clinical reasoning. It has become moral bookkeeping in medical language.

Five patients medicine forgot

The specific mechanisms are already documented in the medical literature. They are not rare, they are not new, they are not obscure. What is rare is a first-line clinician who thinks to look for them when a patient’s weight goes up.

Rachel, 48. Gained six kilos over three years without changing what she ate. Fasting glucose normal, so the workup stopped. After three years of failed diets, an endocrinologist finally measured her fasting insulin: 22 μIU/mL, with a HOMA-IR well into the resistance range. She was compensating chronic hyperinsulinemia. A shift to a lower-carbohydrate pattern and a course of metformin brought her insulin down. Her hunger recalibrated over three months. She lost eight kilos over the following year without keeping a diary. What had to change was not what she ate. It was how her cells were interpreting it.

Sarah, 42. Was gaining a kilo every two months, with rising fatigue, constipation, hair thinning, cold hands. Her TSH was 3.2 mIU/L, technically inside the reference range. Her free T4 was normal. She was told she was fine. A curious clinician measured her free T3: near the floor. Her ferritin was 18 μg/L. The deiodinases that convert T4 into the active T3 depend on iron; without iron, the active thyroid hormone is not made. Iron was restored, then modest T3 supplementation was added for three months. Her T3 rose. Her energy returned, her hunger returned to a regulated pattern, her weight started to fall.

Anna, 44. Obese for twenty years, chronically exhausted, repeatedly prescribed ferrous sulfate and each time labeled iron-intolerant. Each time restarted on a diet. One day a physician ordered the full panel: ferritin 300 μg/L (superficially reassuring), serum iron low, transferrin saturation 10%, CRP 8 mg/L. Her hepcidin was elevated by chronic low-grade inflammation and was blocking every oral iron she swallowed. Three infusions of intravenous ferric carboxymaltose changed the trajectory. Two months later she was moving on her own accord for the first time in years, her appetite had a shape again, and she was four kilos lighter without any dietary intervention.

Deborah, 51. Snored heavily, woke tired despite eight hours in bed, had been gaining slowly for a decade, was somnolent through the afternoon, and never once felt the impulse to move at that time of day. A polysomnography showed an apnea-hypopnea index of 32, in the severe range. She was fitted with a CPAP. Three months later her daytime energy had returned and with it a spontaneous mobility no one had prescribed. Her weight began to decline on its own.

Michelle, 39. Had gained fourteen kilos in two years since starting olanzapine for bipolar II. No one had told her that a large fraction of patients on this medication gain more than seven percent of their body weight, or that the mechanism is a pharmacological retuning of appetite and glucose handling, not a slackening of will. She believed she had let herself go. An attentive psychiatrist switched her to a weight-neutral antipsychotic. Over six months she lost nine kilos without changing a single habit. What had changed was not her behavior. It was her pharmacology.

Each of these five carries the same pattern. The body had been modified by an identifiable biological factor. The counting could not resolve the problem, because the problem was not at the level of the count. The return to a functioning regulation was obtained by an intervention that addressed the machinery, not the ledger. In each case, the intervening physician had done nothing exotic. She or he had simply run a workup that first-line practice had failed, for years, to run.

Less common tableaux exist and belong in the same list: Cushing’s syndrome, insulinoma, severe polycystic ovary syndrome, hypothalamic obesity after craniopharyngioma. For the specialists who know how to recognize them, each has its own medicine. They are mentioned here so that the reader with an atypical presentation knows there is a name for it. The five above are the ones most often missed in ordinary practice.

Ozempic, or the confirmation nobody asked for

Meanwhile, in the same years, a class of drugs called GLP-1 agonists has crossed from diabetes clinics into mass use. Millions of people are now taking them, and a large fraction are losing weight for the first time in decades of trying. The public discussion insists on calling these drugs appetite suppressants, as though the treatment worked by adding willpower where willpower was missing. This is not what the drugs do. They restore a signal. They slow gastric emptying, they act on central satiety pathways, they improve insulin sensitivity. They repair, imperfectly and pharmacologically, a regulatory circuit that had been broken. The patients who no longer feel hungry all day are not disciplined for the first time in their lives. They are receiving, for the first time, a physiological signal that had gone quiet.

The confirmation is embarrassing for the calorie paradigm. If weight were governed by intake minus expenditure, a drug that made people less interested in food would be a nutritional aid at best. Instead, a drug that acts on the regulatory machinery has produced shifts in weight that no diet had produced in the same patients over decades of trying. The paradigm has been refuted at population scale, and the industry that markets the refutation calls it a coincidence of appetite. Everyone can see it. The pharmacology says the machinery is the site. The public discussion says the machinery is the mouth.

The cost

How many hypothyroidisms were diagnosed only after the patient had spent a decade being told to eat less. How many iron deficiencies were called iron intolerance. How many polycystic ovary syndromes were put on diets before anyone measured a hormone. How many sleep apneas were missed while the patient was scolded for a laziness she could not fight, because she had not slept in five years. How many pharmacological weight gains were blamed on the patient’s character while the prescription pad continued to write olanzapine.

Each of these is a diagnosis delayed by years, in a population that reported its symptoms and was answered with a brochure. The delay is not a rounding error. It is decades of life spent inside a body that was calling out for care and being told to weigh itself instead.

The asymmetry has a body count. Someone should be measuring it.

The gulf

I do not count. I have never counted. I eat a lot, and I have moved very little for long stretches of my adult life. Whatever my body does when it decides what to store or burn, it does it below the level of my conscious attention, and I have let it. I mention this not as a virtue, and not as an example to be imitated. I mention it because the great majority of the human population, for the great majority of history, has lived like this. Silent regulation is what the machinery is for.

What I feel about the people who now carry the ledger is closer to grief than to disagreement. They did not choose the ledger. It was installed in them by the same institutions that claim to care for their health. They watch their plates and their staircases with a vigilance no one asked of me. Some have spent whole adult lives inside a private accounting that could not, even in principle, have addressed the machinery that was quietly going wrong.

I would like to imagine a world in which a person who gains weight is asked what is your body doing, in the same tone, with the same seriousness, and with the same reflex to open a laboratory workup, that greeted her lean neighbor’s unexplained loss. Her weight would be a signal. She would be heard. The machinery would be examined. If a diagnosis were found, it would be named. If a treatment existed, it would be offered. If none existed yet, the search for one would begin, in place of the search for her failure of will.

A right, and a question

Physiological rights, in the way this resource uses the term, are rights to the material conditions of a functioning body. The right at stake here is the right to the same workup, in both directions of weight change. The right to be a patient of one’s body, not a defendant of one’s plate.

The question that would honor this right, at every first-line consultation where an obese person reports having gained weight without changing what she eats, is the question already asked of her lean neighbor:

What is your body doing?